Benjamin Machinas Beneski - 31 Mar 2026 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Reporting relationship: SVP, Chief Technical Officer
Issuer ticker: ALLO
Reported as of: 31 Mar 2026
Net transaction value: -$7,168
SEC form: 4
Accepted by SEC: 02 Apr 2026, 16:47:39 UTC
Prior SEC filing: 18 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/Earl Douglas, Attorney-in-Fact

Key filing fact

Benjamin Machinas Beneski filed Form 4 for Allogene Therapeutics, Inc. (ALLO) on 02 Apr 2026.

Key facts

This page summarizes Benjamin Machinas Beneski's Form 4 filing for Allogene Therapeutics, Inc. (ALLO).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 Apr 2026, 16:47.

Change

Previous filing in this sequence was filed on 18 Mar 2026.
Current net transaction value: -$7,168.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002057918 Primary reporting owner

Beneski Benjamin Machinas

Relationship: SVP, Chief Technical Officer
Address: 210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO
Signature: /s/Earl Douglas, Attorney-in-Fact
Signature date: 02 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ALLO transaction

Common Stock

Sale

Transaction value: $7,168
Shares: -2,867
Change %: -1.4%
Price: $2.50
Shares after: 195,338
Date: 31 Mar 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.